Surgery for limited liver or lung pancreatic cancer spread
Part of Cancer clinical trials.
This trial tests whether removing or ablating limited liver or lung tumors from pancreatic cancer that has not spread elsewhere, along with a specific chemotherapy (NALIRIFOX), can help patients. It is for people who have not had any previous cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that has spread to only 1 to 5 spots in the liver or up to 4 spots in the lung, and no other distant spread.
- You have not received any prior cancer treatments for this pancreatic cancer.
- You are able to do your daily activities with little or no help (ECOG 0-1).
- You are age 18 or older.
- You are a candidate for a chemotherapy regimen called NALIRIFOX.
- You do not have active hepatitis B or C, HIV, or Gilbert's syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with pancreatic cancer that has spread to the liver (3 spots or fewer). It tests whether removing both the original tumor and the liver spots after a specific chemotherapy (FOLFIRINOX) can be helpful. You may be eligible if the chemo shrinks the tumors enough and you are healthy enough for surgery.
This trial compares surgery to remove the primary tumor and up to 3 liver spots against standard palliative care for people with pancreatic cancer that has spread only to the liver (up to 3 spots). It is for those whose cancer has not grown after initial chemotherapy and who are healthy enough for surgery.
This study tests whether surgery to remove liver tumors from pancreatic cancer can improve outcomes. It is for patients whose cancer has spread only to the liver, and the tumor can be safely removed or destroyed.
This trial tests a treatment for pancreatic cancer that has spread to the liver (with no more than a few liver tumors). Patients will receive chemotherapy plus surgery and a heat-based procedure (thermal ablation) to destroy the liver tumors. The goal is to see if combining these treatments helps control the cancer better than chemotherapy alone.
This trial tests a combination of chemotherapy drugs (liposomal irinotecan with fluorouracil, leucovorin, and oxaliplatin) given before and after surgery for pancreatic cancer that can be fully removed. It aims to see if this approach improves outcomes for patients with stage I or II disease.
This trial tests a combination of standard chemotherapy, MRI-guided radiation, and surgery for people with locally advanced pancreatic cancer that might be removable. The goal is to see if this approach can make more tumors resectable.
Hear when a new Adenocarcinoma of the Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.